Radiotherapy of T1c prostate cancer
- PMID: 8521132
Radiotherapy of T1c prostate cancer
Abstract
With a 10-year local control rate of 85% to 100% and a low complication rate, radiotherapy is an effective treatment option for T1c prostate cancer. Controversial topics, such as treatment volumes and dose-response, are critically reviewed. New investigational approaches will be discussed.
Publication types
MeSH terms
LinkOut - more resources
Medical